Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
0.4200
+0.0240
+(6.06%)
At close: February 26 at 3:00:00 PM EST
Breakdown
12/31/2023
12/31/2022
12/31/2021
Total Assets
2,170
2,794
2,836
Total Liabilities Net Minority Interest
1,981
698
1,659
Total Equity Gross Minority Interest
189
2,096
1,177
Total Capitalization
189
2,096
1,177
Common Stock Equity
189
2,096
1,177
Capital Lease Obligations
20
44
--
Net Tangible Assets
189
2,096
1,177
Working Capital
74
2,089
1,205
Invested Capital
189
2,096
2,220
Tangible Book Value
189
2,096
1,177
Total Debt
20
44
1,043
Share Issued
48,249.7070
42,855.1580
42,855.1580
Ordinary Shares Number
48,249.7070
42,855.1580
42,855.1580
12/31/2021 - 11/10/2023
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
4PKB.F LAVA Therapeutics N.V.
1.2200
+38.64%
NLSPW NLS Pharmaceutics AG
0.0129
+12.17%
BIXT Bioxytran, Inc.
0.0780
0.00%
COEPW Coeptis Therapeutics Holdings, Inc.
0.0230
+15.00%
MRES Institute of Biomedical Research Corp.
0.0172
0.00%
KLTO Klotho Neurosciences, Inc.
0.3620
+1.69%
AVTE Aerovate Therapeutics, Inc.
2.4300
+0.83%
NGEN.V NervGen Pharma Corp.
2.7500
-0.36%
TSOI Therapeutic Solutions International, Inc.
0.0003
0.00%
NGENF NervGen Pharma Corp.
1.9200
-0.52%